Intra-Cellular Therapies
Why Robinhood?
You can watch ITCI and buy or sell other stocks, ETFs, and their options commission-free!About ITCI
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system.
ITCI Key Statistics
Stock Snapshot
Intra-Cellular Therapies(ITCI) stock is priced at $131.87, giving the company a market capitalization of 14.01B. It carries a P/E multiple of -182.70.
On 2026-03-01, Intra-Cellular Therapies(ITCI) stock opened at —, reached a high of —, and a low of —.
The Intra-Cellular Therapies(ITCI)'s current trading volume is 0, compared to an average daily volume of 1.9M.
During the past year, Intra-Cellular Therapies(ITCI) stock moved between $64.09 at its lowest and $131.98 at its peak.
During the past year, Intra-Cellular Therapies(ITCI) stock moved between $64.09 at its lowest and $131.98 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.